These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1781380)

  • 21. Adenosine deaminase inhibition attenuates microvascular dysfunction and improves survival in sepsis.
    Cohen ES; Law WR; Easington CR; Cruz KQ; Nardulli BA; Balk RA; Parrillo JE; Hollenberg SM
    Am J Respir Crit Care Med; 2002 Jul; 166(1):16-20. PubMed ID: 12091165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
    Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
    Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
    Thuillier L; Garreau F; Cartier PH
    Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of viramidine to ribavirin in vivo by adenosine deaminase and its inhibition by 2'-deoxycoformycin.
    Wu JZ; Yeh LT; Lin CC; Hong Z
    Antivir Chem Chemother; 2006; 17(1):33-9. PubMed ID: 16542004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
    Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R
    Pharmacol Res; 2007 Aug; 56(2):124-31. PubMed ID: 17574432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine deaminase-deficient mice: models for the study of lymphocyte development and adenosine signaling.
    Aldrich MB; Blackburn MR; Datta SK; Kellems RE
    Adv Exp Med Biol; 2000; 486():57-63. PubMed ID: 11783528
    [No Abstract]   [Full Text] [Related]  

  • 27. Transition-state discrimination by adenosine deaminase from Aspergillus oryzae.
    Grosshans J; Wolfenden R
    Biochim Biophys Acta; 1993 Jan; 1161(1):28-32. PubMed ID: 8422418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.
    Hershfield MS; Kredich NM; Ownby DR; Ownby H; Buckley R
    J Clin Invest; 1979 Apr; 63(4):807-11. PubMed ID: 312296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine-mediated killing of cultured epithelial cancer cells.
    Barry CP; Lind SE
    Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of deoxyribonucleotides as a possible mediator of immunosuppression in hereditary deficiency of adenosine deaminase.
    Bluestein HG; Willis RC; Thompson LF; Matsumoto S; Seegmiller JE
    Trans Assoc Am Physicians; 1978; 91():394-402. PubMed ID: 314193
    [No Abstract]   [Full Text] [Related]  

  • 31. Nucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombination.
    Gangi-Peterson L; Sorscher DH; Reynolds JW; Kepler TB; Mitchell BS
    J Clin Invest; 1999 Mar; 103(6):833-41. PubMed ID: 10079104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of adenosine deaminase for lymphocyte development and function.
    Aldrich MB; Blackburn MR; Kellems RE
    Biochem Biophys Res Commun; 2000 Jun; 272(2):311-5. PubMed ID: 10833410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does adenosine deaminase inhibition protect ischemic myocardium?
    Gallagher KP; McClanahan TB; Martin BJ; Saganek LJ; Ignasiak DP; Mertz TE; Van Wylen DG; Vinten-Johansen J
    Adv Exp Med Biol; 1994; 370():291-4. PubMed ID: 7660911
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD; Ip H; Pereira S
    Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity of cordycepin in combination with the adenosine deaminase inhibitor 2'-deoxycoformycin in beagle dogs.
    Rodman LE; Farnell DR; Coyne JM; Allan PW; Hill DL; Duncan KL; Tomaszewski JE; Smith AC; Page JG
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):39-45. PubMed ID: 9356305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of possible relation of defects in purine metabolism to immune deficiency.
    Seegmiller JE
    Ann N Y Acad Sci; 1985; 451():9-19. PubMed ID: 3935028
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of African trypanosomiasis with cordycepin and adenosine deaminase inhibitors in a mouse model.
    Rottenberg ME; Masocha W; Ferella M; Petitto-Assis F; Goto H; Kristensson K; McCaffrey R; Wigzell H
    J Infect Dis; 2005 Nov; 192(9):1658-65. PubMed ID: 16206083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
    Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
    J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential for transient inhibition of adenosine deaminase in systemic inflammatory response syndrome.
    Law WR; Valli VE; Conlon BA
    Crit Care Med; 2003 May; 31(5):1475-81. PubMed ID: 12771621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.
    Apasov SG; Blackburn MR; Kellems RE; Smith PT; Sitkovsky MV
    J Clin Invest; 2001 Jul; 108(1):131-41. PubMed ID: 11435465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.